Results

RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/SHA-384/A96819228B5BC5C8F7811CDB129A4FC1CBEB9497C968093462D8B7864769F3B9CB1B5B522394744E6F2314CD5B0D1FEFhttp://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/A96819228B5BC5C8F7811CDB129A4FC1CBEB9497C968093462D8B7864769F3B9CB1B5B522394744E6F2314CD5B0D1FEFhttp://www.w3.org/2000/01/rdf-schema#comment"Study found that mutations in TET1 a DNA demethylase was predictive of higher objective response rate (ORR) better durable clinical benefit (DCB) longer progression-free survival (PFS) and improved overall survival (OS) to immune checkpoint inhibitors treatment across multiple cancer types."xsd:string
http://purl.uniprot.org/uniprot/#_FD01C421231ACB182F333ED9FE7136064F0D20FFA5488FBF2931EFEF4D2B30F8CA59004E44C7489863CA40A210B56EAEhttp://www.w3.org/1999/02/22-rdf-syntax-ns#subjecthttp://purl.uniprot.org/SHA-384/A96819228B5BC5C8F7811CDB129A4FC1CBEB9497C968093462D8B7864769F3B9CB1B5B522394744E6F2314CD5B0D1FEF
http://purl.uniprot.org/uniprot/B3W6H5http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/A96819228B5BC5C8F7811CDB129A4FC1CBEB9497C968093462D8B7864769F3B9CB1B5B522394744E6F2314CD5B0D1FEF
http://purl.uniprot.org/uniprot/#_B3W6H5-mappedCitation-31623662http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/A96819228B5BC5C8F7811CDB129A4FC1CBEB9497C968093462D8B7864769F3B9CB1B5B522394744E6F2314CD5B0D1FEF